N-Phenethyl and N-naphthylmethyl isatins and analogues as in vitro cytotoxic agents
摘要:
A range of N-phenethyl, N-phenacyl, and N-(1- and 2-naphthylmethyl) derivatives of 5,7-dibromoisatin 2 were prepared by N-alkylation reactions. Their activity against human monocyte-like histiocytic lymphoma (U937), leukemia (Jurkat), and breast carcinoma (MDA-MB-231) cell lines was assessed. The results allowed further development of structure-activity relationships. The compound 5,7-dibromo-N-(1-naphthylmethyl)-1H-indole-2,3-dione 5a was the most potent against U937 cells with an IC50 value of 0.19 mu M. (C) 2007 Elsevier Ltd. All rights reserved.
[EN] SELECTIVELY DELIVERABLE ISATIN-BASED CYTOTOXIC AGENTS<br/>[FR] AGENTS CYTOTOXIQUES À BASE D'ISATINE POUVANT ÊTRE ADMINISTRÉS SÉLECTIVEMENT
申请人:UNIV WOLLONGONG
公开号:WO2008074078A1
公开(公告)日:2008-06-26
[EN] The invention relates to compounds comprising a cytotoxic isatin derivative conjugated to a cell targeting moiety via a spacer group. These conjugates allow the cytotoxic isatin derivaties to be targeted to particular cell and tissue types. The invention also relates to novel isatin derivatives, intermediates used in preparing the conjugates and method of using the conjugates. [FR] L'invention concerne des composés contenant un dérivé d'isatine cytotoxique conjugué à un groupe fonctionnel de ciblage cellulaire au moyen d'un groupe espaceur. Ces conjugués permettent de cibler les dérivés d'isatine cytotoxiques sur des types de cellules et de tissus particuliers. L'invention concerne également de nouveaux dérivés d'isatine, des intermédiaires employés dans la préparation des conjugués et un procédé d'utilisation des conjugués.
N-Phenethyl and N-naphthylmethyl isatins and analogues as in vitro cytotoxic agents
作者:Lidia Matesic、Julie M. Locke、John B. Bremner、Stephen G. Pyne、Danielle Skropeta、Marie Ranson、Kara L. Vine
DOI:10.1016/j.bmc.2007.12.026
日期:2008.3.15
A range of N-phenethyl, N-phenacyl, and N-(1- and 2-naphthylmethyl) derivatives of 5,7-dibromoisatin 2 were prepared by N-alkylation reactions. Their activity against human monocyte-like histiocytic lymphoma (U937), leukemia (Jurkat), and breast carcinoma (MDA-MB-231) cell lines was assessed. The results allowed further development of structure-activity relationships. The compound 5,7-dibromo-N-(1-naphthylmethyl)-1H-indole-2,3-dione 5a was the most potent against U937 cells with an IC50 value of 0.19 mu M. (C) 2007 Elsevier Ltd. All rights reserved.